Effect of Mahuang Fuzi and Shenzhuo Decoction on Idiopathic Membranous Nephropathy: A Multicenter, Nonrandomized, Single-Arm Clinical Trial
Objective: To explore the clinical effect of Mahuang Fuzi and Shenzhuo Decoction on idiopathic membranous nephropathy.Methods: This study is a multicenter, nonrandomized, single-arm clinical trial carried out as per the objective performance criteria, with the target being set at 35.0%. 184 cases of...
Main Authors: | Zhaocheng Dong, Haoran Dai, Yu Gao, Hanxue Jiang, Meiqi Liu, Fei Liu, Wenbin Liu, Zhendong Feng, Xiaoyan Zhang, Aijie Ren, Xiaolan Li, Hongliang Rui, Xuefei Tian, Guiming Li, Baoli Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.724744/full |
Similar Items
-
Efficacy and safety of Mahuang Fuzi and Shenzhuo Decoction for treatment of primary membranous nephropathy: a multicenter prospective trial
by: Naiqian Zhang, et al.
Published: (2024-12-01) -
The Ameliorative Effect of Mahuang Fuzi and Shenzhuo Decoction on Membranous Nephropathy of Rodent Model is Associated With Autophagy and Wnt/β-Catenin Pathway
by: Yu Gao, et al.
Published: (2022-04-01) -
Activation of the IL-6/STAT3 pathway contributes to the pathogenesis of membranous nephropathy and is a target for Mahuang Fuzi and Shenzhuo Decoction (MFSD) to repair podocyte damage
by: Qihan Zhao, et al.
Published: (2024-05-01) -
Level of interleukin-35 in patients with idiopathic membranous nephropathy and its predictive value for remission time
by: Na Zhang, et al.
Published: (2022-08-01) -
Decoction regulating phytochemicals’ micromorphology changes and anti-inflammation activity enhancements originated from herb medicine supermolecules
by: Luping Yang, et al.
Published: (2024-01-01)